Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

32.72 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Revenue 714.734582.022437.855305.44159.7425.9950
Cost of Revenue 156.815121.23683.48155.51827.7381.5770.184
Gross Profit 557.919460.786354.374249.922132.0044.418-0.184
Gross Profit Ratio 0.7810.7920.8090.8180.8260.7370
Reseach & Development Expenses 145.82576.06370.88630.36719.44869.59512.372
General & Administrative Expenses 110.35295.28984.01763.90939.74636.40912.206
Selling & Marketing Expenses 110.91697.40479.28568.11855.82444.31816.861
SG&A 221.268192.693163.302132.02795.5780.72729.067
Other Expenses 000.1690.016-3.07100
Operating Expenses 367.093268.756234.188162.394115.018150.32241.439
Operating Income 190.826192.03120.18668.7043.678-145.904-41.439
Operating Income Ratio 0.2670.330.2740.2250.023-24.3380
Total Other Income Expenses Net 0.978-18.634-15.5-50.1-53.93-6.0731.541
Income Before Tax 191.804173.396104.68637.428-36.944-151.977-39.898
Income Before Tax Ratio 0.2680.2980.2390.123-0.231-25.3510
Income Tax Expense 46.31144.543-76.7822.83114.9126.0731.541
Net Income 145.493128.853181.46834.597-51.856-158.05-39.898
Net Income Ratio 0.2040.2210.4140.113-0.325-26.3640
EPS 2.562.173.070.6-0.91-2.48-0.81
EPS Diluted 2.512.132.970.58-0.91-2.48-0.81
EBITDA 233.412221.512143.571106.3681.513-142.694-41.255
EBITDA Ratio 0.3270.3810.2750.2870.087-23.8020